Visualization of physical interactions in augmented reality
US-2017103581-A1 · Apr 13, 2017 · US
US12588967B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12588967-B2 |
| Application number | US-202117999986-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 28, 2021 |
| Priority date | May 29, 2020 |
| Publication date | Mar 31, 2026 |
| Grant date | Mar 31, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Novel tools and techniques are provided for presenting patient information to a user. In some embodiments, a computer system may: receive device data associated with one or more devices configured to perform a cardiac shunting procedure to change a cardiac blood flow pattern to improve cardiac blood flow efficiency or cardiac pumping efficiency; receive one or more imaging data associated with one or more imaging devices configured to generate images of one or more internal portions of the patient; analyze the device data and the imaging data; map the device data and the imaging data to a multi-dimensional representation of the one or more internal portions of the patient; generate one or more image-based outputs based at least in part on the mapping; and present, using a user experience (“UX”) device, the generated one or more image-based outputs.
Opening claim text (preview).
What is claimed is: 1 . A method for presenting patient information to a user, the method comprising: receiving, with a computing system, one or more device data associated with each of one or more devices, wherein the one or more devices are configured to perform a cardiac shunting procedure to change a cardiac blood flow pattern to improve cardiac blood flow efficiency or cardiac pumping efficiency; receiving, with the computing system, one or more imaging data associated with each of one or more imaging devices configured to generate images of one or more internal portions of a patient; analyzing, with the computing system, the received one or more device data and the received one or more imaging data; mapping, with the computing system, the received one or more device data and the received one or more imaging data to a multi-dimensional representation of the one or more internal portions of the patient, based at least in part on the analysis, wherein the multi-dimensional representation comprises data corresponding to three dimensions, four dimensions, or more than four dimensions; generating, with the computing system, one or more extended reality (“XR”) experiences, based at least in part on the mapping, wherein the one or more XR experiences include at least one visual XR experience and at least one non-visual XR experience; and presenting, with the computing system and using a user experience (“UX”) device, the generated one or more XR experiences. 2 . The method of claim 1 , wherein the computing system comprises at least one of a medical procedure computing system, a hub computing system, a three-dimensional (“3D”) graphical processing unit, a cluster computing system, a four-dimensional (“4D”) graphics computing system, a server computer, a cloud computing system, or a distributed computing system. 3 . The method of claim 1 , wherein the one or more devices comprise at least one of one or more catheters, one or more catheter interconnect or interface cables, one or more valves, one or more balloons, one or more leads, one or more pacemakers, one or more defibrillators, one or more neuromodulation devices, one or more neurostimulation devices, one or more rigid robotic devices, one or more soft robotic devices, one or more stents, one or more needles, one or more occluders, one or more shunts, one or more diagnostic catheters, one or more surgical tools, one or more ablation tools, one or more monitoring devices, one or more cameras, one or more imaging tools, one or more fiducials, one or more staples, one or more anchors, one or more meshes, one or more vascular cannulae, one or more circulatory pumps, one or more valve repair devices, one or more embolic protection devices, one or more cardiomyoplasty tools, one or more vascular closure tools, one or more septal closure tools, one or more ventricular closure tools, one or more lasers, one or more plaque removal tools, one or more guide wires, one or more introducers, one or more sheaths, one or more clips, one or more capsules, one or more energy delivery tools, a pulmonary vein ablation catheter (“PVAC”), a catheter electrode distribution system (“CEDS”), a pulsed field ablation (“PFA”) system, a PFA console, an electroporation system, an electroporation control console, a cryoballoon or a cryoablation catheter, a cryoablation console, a radio frequency (“RF”) ablation-based system, an RF ablation control console, a microwave (“MW”) ablation-based system, a MW ablation control console, a laser ablation-based system, a laser ablation control console, a radiation ablation-based system, a radiation ablation control console, a microwave ablation-based system, a high intensity focused ultrasound (“HIFU”) system, a HIFU control console, an implantable cardioverter defibrillator (“ICD”) device, an extravascular ICD (“EV-ICD”), a miniature leadless implant, or one or more implantable sensors. 4 . The method of claim 3 , wherein the one or more devices comprise at least one of one or more soft robotic devices, one or more shunts, a catheter electrode distribution system (“CEDS”), a pulsed field ablation (“PFA”) system, a PFA console, a cryoballoon or a cryoablation catheter, a cryoablation console, a microwave (“MW”) ablation-based system, or a MW ablation control console. 5 . The method of claim 1 , wherein the one or more imaging devices comprise at least one of a magnetic resonance imaging (“MRI”) system, a diffusion-tensor imaging (“DTI”) system, a computed tomography (“CT”) system, an ultrasound (“US”) system, a transesophageal echocardiography (“TEE”) system, an intra-cardiac echocardiography (“ICE”) system, a transthoracic echocardiography (“TTE”) system, an intravascular ultrasound (“IVUS”) system, an electromechanical wave imaging (“EWI”) system, a neuro-endoscopy system, a single photon emission computed tomography (“SPECT”) system, a magnetic resonance angiography (“MRA”) system, a computed tomography angiography (“CTA”) system, a blood oxygen-level dependent signal (“BOLD”) system, an arterial spin labeling (“ASL”) system, a magnetoencephalography (“MEG”) system, a positron emission tomography (“PET”) system, an electroencephalography (“EEG”) system, an optical coherence tomography (“OCT”) system, an optical imaging spectroscopy (“OIS”) system, a magnetic resonance spectroscopy (“MRS”) system, a dynamic susceptibility contrast (“DSC”) MRI system, a fluid-attenuated inversion recovery (“FLAIR”) system, a fluoroscopy system, an X-ray system, a 3D scanning system, an infrared (“IR”) system, an ultraviolet (“UV”) system, a bioluminescent system, an endoscopy system, a triboluminescence system, an image fusion system, or a microscope. 6 . The method of claim 5 , wherein the one or more imaging devices comprise at least one of a magnetic resonance imaging (“MRI”) system, a computed tomography (“CT”) system, an ultrasound (“US”) system, an electromechanical wave imaging (“EWI”) system, a fluoroscopy system, a 3D scanning system, or an infrared (“IR”) system. 7 . The method of claim 1 , wherein the cardiac shunting procedure comprises at least one of a surgical procedure, a left atrial appendage (“LAA”) procedure, a tissue ablation procedure, a transcatheter aortic valve repair (“TAVr”) procedure, a transcatheter aortic valve replacement (“TAVR”) procedure, a transcatheter mitral valve repair (“TMVr”) procedure, a transcatheter mitral valve replacement (“TMVR”) procedure, a transcatheter pulmonic valve repair (“TPVr”) procedure, a transcatheter pulmonic valve replacement (“TPVR”) procedure, a transcatheter tricuspid valve repair (“TTVr”) procedure, a transcatheter tricuspid valve replacement (“TTVR”) procedure, a mitral clip repair procedure, a shunt procedure, a coronary angioplasty procedure, a balloon angioplasty, a stenting procedure, an atrial septal defect (“ASD”) treatment procedure, a cardiac shunt treatment procedure, a heart bypass procedure, a cardiac mapping procedure, a cardiac resynchronization therapy (“CRT”) device installation procedure, a catheter ablation procedure, an endovascular repair procedure, a heart monitor installation procedure, an implantable cardioverter defibrillator (“ICD”) device installation procedure, an extravascular ICD (“EV-ICD”) device installation procedure, a minimally invasive endovascular repair procedure, a miniature leadless implant installation procedure, an implantable sensor installation procedure, a surgical heart valve repair and replacement procedure, a transcatheter pulmonary valve (“TPV”) therapy, a ventricular assist device (“VAD”) installation procedure, an intra-aortic balloon pump (“IABP”) implantation procedure, a heart transplant operation, a cryoballoon or cryoablation catheter procedure, a pulsed field ablation (“PFA”) procedure, an electroporation procedure, a rad
involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging · CPC title
Potential distribution indication · CPC title
having a flexible, catheter-like structure, e.g. for heart ablation (A61B18/1477 takes precedence) · CPC title
using impedance sensors · CPC title
for the heart · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.